BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 29042430)

  • 1. Ideal Cardiovascular Health and Incident Cardiovascular Disease: Heterogeneity Across Event Subtypes and Mediating Effect of Blood Biomarkers: The PRIME Study.
    Gaye B; Tafflet M; Arveiler D; Montaye M; Wagner A; Ruidavets JB; Kee F; Evans A; Amouyel P; Ferrieres J; Empana JP
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.
    Pradhan AD; Manson JE; Rossouw JE; Siscovick DS; Mouton CP; Rifai N; Wallace RB; Jackson RD; Pettinger MB; Ridker PM
    JAMA; 2002 Aug; 288(8):980-7. PubMed ID: 12190368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial.
    Held C; White HD; Stewart RAH; Budaj A; Cannon CP; Hochman JS; Koenig W; Siegbahn A; Steg PG; Soffer J; Weaver WD; Östlund O; Wallentin L;
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cigarette smoking and cardiovascular events: role of inflammation and subclinical atherosclerosis from the MultiEthnic Study of Atherosclerosis.
    McEvoy JW; Blaha MJ; DeFilippis AP; Lima JA; Bluemke DA; Hundley WG; Min JK; Shaw LJ; Lloyd-Jones DM; Barr RG; Budoff MJ; Blumenthal RS; Nasir K
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):700-9. PubMed ID: 25573855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Plasma γ' Fibrinogen With Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study.
    Appiah D; Schreiner PJ; MacLehose RF; Folsom AR
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2700-6. PubMed ID: 26494231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).
    Blankenberg S; Luc G; Ducimetière P; Arveiler D; Ferrières J; Amouyel P; Evans A; Cambien F; Tiret L;
    Circulation; 2003 Nov; 108(20):2453-9. PubMed ID: 14581397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The American Heart Association Ideal Cardiovascular Health and Incident Type 2 Diabetes Mellitus Among Blacks: The Jackson Heart Study.
    Effoe VS; Carnethon MR; Echouffo-Tcheugui JB; Chen H; Joseph JJ; Norwood AF; Bertoni AG
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28637777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The associations of interleukin-6 (IL-6) and downstream inflammatory markers with risk of cardiovascular disease: the Caerphilly Study.
    Patterson CC; Smith AE; Yarnell JW; Rumley A; Ben-Shlomo Y; Lowe GD
    Atherosclerosis; 2010 Apr; 209(2):551-7. PubMed ID: 19836021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study.
    Luc G; Bard JM; Juhan-Vague I; Ferrieres J; Evans A; Amouyel P; Arveiler D; Fruchart JC; Ducimetiere P;
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1255-61. PubMed ID: 12775578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
    ; Danesh J; Lewington S; Thompson SG; Lowe GD; Collins R; Kostis JB; Wilson AC; Folsom AR; Wu K; Benderly M; Goldbourt U; Willeit J; Kiechl S; Yarnell JW; Sweetnam PM; Elwood PC; Cushman M; Psaty BM; Tracy RP; Tybjaerg-Hansen A; Haverkate F; de Maat MP; Fowkes FG; Lee AJ; Smith FB; Salomaa V; Harald K; Rasi R; Vahtera E; Jousilahti P; Pekkanen J; D'Agostino R; Kannel WB; Wilson PW; Tofler G; Arocha-Piñango CL; Rodriguez-Larralde A; Nagy E; Mijares M; Espinosa R; Rodriquez-Roa E; Ryder E; Diez-Ewald MP; Campos G; Fernandez V; Torres E; Marchioli R; Valagussa F; Rosengren A; Wilhelmsen L; Lappas G; Eriksson H; Cremer P; Nagel D; Curb JD; Rodriguez B; Yano K; Salonen JT; Nyyssönen K; Tuomainen TP; Hedblad B; Lind P; Loewel H; Koenig W; Meade TW; Cooper JA; De Stavola B; Knottenbelt C; Miller GJ; Cooper JA; Bauer KA; Rosenberg RD; Sato S; Kitamura A; Naito Y; Palosuo T; Ducimetiere P; Amouyel P; Arveiler D; Evans AE; Ferrieres J; Juhan-Vague I; Bingham A; Schulte H; Assmann G; Cantin B; Lamarche B; Després JP; Dagenais GR; Tunstall-Pedoe H; Woodward M; Ben-Shlomo Y; Davey Smith G; Palmieri V; Yeh JL; Rudnicka A; Ridker P; Rodeghiero F; Tosetto A; Shepherd J; Ford I; Robertson M; Brunner E; Shipley M; Feskens EJ; Kromhout D; Dickinson A; Ireland B; Juzwishin K; Kaptoge S; Lewington S; Memon A; Sarwar N; Walker M; Wheeler J; White I; Wood A
    JAMA; 2005 Oct; 294(14):1799-809. PubMed ID: 16219884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ideal cardiovascular health and incidence of atherosclerotic cardiovascular disease among Chinese adults: the China-PAR project.
    Han C; Liu F; Yang X; Chen J; Li J; Cao J; Li Y; Shen C; Yu L; Liu Z; Wu X; Zhao L; Hu D; Lu X; Wu X; Gu D
    Sci China Life Sci; 2018 May; 61(5):504-514. PubMed ID: 29721777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study.
    Scarabin PY; Arveiler D; Amouyel P; Dos Santos C; Evans A; Luc G; Ferrières J; Juhan-Vague I;
    Atherosclerosis; 2003 Jan; 166(1):103-9. PubMed ID: 12482556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Cardiovascular Health With Subclinical Disease and Incident Events: The Multi-Ethnic Study of Atherosclerosis.
    Polonsky TS; Ning H; Daviglus ML; Liu K; Burke GL; Cushman M; Eng J; Folsom AR; Lutsey PL; Nettleton JA; Post WS; Sacco RL; Szklo M; Lloyd-Jones DM
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28320747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple biomarkers for the prediction of ischemic stroke: the PRIME study.
    Prugger C; Luc G; Haas B; Morange PE; Ferrieres J; Amouyel P; Kee F; Ducimetiere P; Empana JP;
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):659-66. PubMed ID: 23329137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Education, socioeconomic and lifestyle factors, and risk of coronary heart disease: the PRIME Study.
    Yarnell J; Yu S; McCrum E; Arveiler D; Hass B; Dallongeville J; Montaye M; Amouyel P; Ferrières J; Ruidavets JB; Evans A; Bingham A; Ducimetière P;
    Int J Epidemiol; 2005 Apr; 34(2):268-75. PubMed ID: 15319403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between High-Sensitivity C-Reactive Protein and Total Stroke by Hypertensive Status Among Men.
    Jiménez MC; Rexrode KM; Glynn RJ; Ridker PM; Gaziano JM; Sesso HD
    J Am Heart Assoc; 2015 Sep; 4(9):e002073. PubMed ID: 26391131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease.
    Tanne D; Haim M; Goldbourt U; Boyko V; Doolman R; Adler Y; Brunner D; Behar S; Sela BA
    Stroke; 2003 Mar; 34(3):632-6. PubMed ID: 12624283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein, interleukin 6, fibrinogen and risk of sudden death in European middle-aged men: the PRIME study.
    Empana JP; Jouven X; Canouï-Poitrine F; Luc G; Tafflet M; Haas B; Arveiler D; Ferrieres J; Ruidavets JB; Montaye M; Yarnell J; Morange P; Kee F; Evans A; Amouyel P; Ducimetiere P
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):2047-52. PubMed ID: 20651278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-High-Density Lipoprotein Cholesterol and Risk of Stroke Subtypes and Coronary Heart Disease: The Japan Public Health Center-Based Prospective (JPHC) Study.
    Saito I; Yamagishi K; Kokubo Y; Yatsuya H; Iso H; Sawada N; Inoue M; Tsugane S
    J Atheroscler Thromb; 2020 Apr; 27(4):363-374. PubMed ID: 31534078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ideal cardiovascular health score and incident end-stage renal disease in a community-based longitudinal cohort study: the Kailuan Study.
    Han QL; Wu SL; Liu XX; An SS; Wu YT; Gao JS; Chen SH; Liu XK; Zhang Q; Mao RY; Shang XM; Jonas JB
    BMJ Open; 2016 Nov; 6(11):e012486. PubMed ID: 27899399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.